Our CEO Dr. Frischmuth shares our newest innovations at RNA Leader conference.
Discover the future of molecular innovation with baseclick. Leading the way in antisense oligonucleotide and mRNA development using Nobel price-winning click chemistry. Visiting our CEO Dr. Thomas Frischmuth at RNA leader conference on 13-14 March 2024 in Basel is a great opportunity to find out more about our current preclinical drug based of sugar modified antisense oligonucleotide. Don’t forget to schedule a meeting and prepare your specific questions about the drug development, potential and timeline for advancement.
